IBANDRONIC ACID Oral monthly

Clinical Indication

Postmenopausal osteoporosis

Comments

In line with NICE TA 464
Use only when compliance with oral therapy is an issue

Date of classification

December 2017

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.